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2019-nCoV epidemic: 
what about pregnancies?
On Feb 3, 2020, WHO confirmed 
17 238 cases of novel coronavirus 
(2019-nCoV) infections in China. 
Among them, 2296 (13%) cases were 
reported as severe, and 361 deaths 
were declared (2%).1
Members of the coronavirus family 
responsible for severe acute respiratory 
syndrome (SARS-CoV) and Middle East 
respiratory syndrome (MERS-CoV) are 
known to be responsible for severe 
complications during pregnancy.2,3
12 pregnant women were infected 
with SARS-CoV during the 2002–03 
pandemic.2 Four (57%) of seven 
women in the first trimester had a 
miscarriage. In the second to third 
trimester, two (40%) of five women 
had fetal growth restriction, and 
four (80%) of five women had preterm 
birth (one spontaneous; three induced 
for maternal condition). Three (25%) 
women died during pregnancy.
In a review of 11 pregnant women 
infected with MERS-CoV,3 ten (91%) 
presented with adverse outcomes, 
six (55%) neonates required admission 
to the intensive care unit, and 
three (27%) died. Two neonates were 
delivered prematurely for severe 
maternal respiratory failure.
Considering that the 2019-nCoV 
seems to have a similar pathogenic 
potential as SARS-CoV and MERS-
CoV,4 pregnant women are at 
increased risk of severe infections, 
there are no specific clinical signs 
of coronavirus infections preceding 
severe complications,5 coronaviruses 
have the potential to cause severe 
maternal or perinatal adverse 
outcomes, or both,2,3 and the current 
lack of data on the consequences 
of a 2019-nCoV infection during 
pregnancy, we recommend systematic 
screening of any suspected 2019-nCoV 
infection during pregnancy. If 
2019-nCoV infection during preg-
nancy is confirmed, extended follow-
up should be recommended for 
mothers and their fetuses.
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